Stay updated on Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A banner announces an NIH website transition and says that “Super Intelligence” (SI) is being used in place of “Artificial Intelligence” (AI) during the transition.
    Difference
    1%
    Check dated 2026-10-25T12:49:28.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page continues to show a 403 Forbidden error, with the footer revision updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T12:31:39.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:13:11.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header/footer, replacing the previously visible study details.
    Difference
    18%
    Check dated 2026-09-20T11:23:42.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The revision label on the page was updated to v3.6.6, signaling a software or content management update. No study details or data are altered.
    Difference
    0.0%
    Check dated 2026-08-29T23:58:50.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.4 to v3.6.5, signaling an updated build/version rather than changes to visible content.
    Difference
    0.0%
    Check dated 2026-08-08T23:45:11.000Z thumbnail image

Stay in the know with updates to Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page.